Stocks To Watch
Arrowhead Research: ‘Early Innings’ for ‘Major Story’
News and commentary about the stocks you need to know about today
March 5, 2014, 11:50 A.M. ET
By Ben Levisohn
Adam Feuerstein @adamfeuerstein 6h
$ARWR DB picks up coverage with a buy. Yesterday it was RBC. This willl be a $100 stock in 2 months.
do the opposite of holly- known on stocktwits to do the opposite
means buy time.
AdamFeuerstein My Blog
Synta Pharma CEO Sudden Resignation Might Trigger Overhaul
By: Adam Feuerstein | 03/04/14
The directors sitting on Synta Pharmaceuticals' (SNTA) board finally looked at the stock chart above or spoke with a real-life oncologist. Either might explain why the company announced the sudden resignation of CEO Safi Bahcall Monday night. Bahcall is being replaced by a committee of directors until a new CEO can be found.
No specific reason was provided for Bahcall's resignation and a company spokesperson wouldn't elaborate. The subpar performance of Synta's stock price during a raging biotech bull market couldn't have helped his case for continued employment. No one but Bahcall really believed in the future of Synta's lead lung cancer drug ganetespib, either.
3 Surging Biotech Stocks to Watch: OncoSec, Clovis, Dyax
Tom Meyer | More Articles
March 03, 2014
Groupon: When Weakness In Stocks Can Be A Good Thing
Feb. 28, 2014 About: GRPN
By George Leong, B.Comm
This is why you should look at sell-offs in popular trading stocks as a buying opportunity to buy at a discounted sale price, rather than chase and buy the stock at higher prices.
It’s not magic or a well-kept secret formula to successful stock market investing, but rather just the insight to buy good companies on temporary weakness, such as Groupon.